Is ABDX or GDR more profitable?

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Abingdon Health -33.88% -55.91% -17.93% genedrive -500.75% -1,044.57% -74.09%

Is GDR or YGEN more profitable?

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Yourgene Health -27.55% -27.06% -6.71%

Which has better earnings and valuation, GDR or VRCI?

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 22.04 -£21.22M -£0.79 N/A Verici Dx £1.91M 3.16 -£6.56M -£2.90 N/A

Is GDR or VRCI more profitable?

Verici Dx has a net margin of -468.31% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -178.37% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Verici Dx -468.31% -178.37% -26.14%

Which has stronger valuation & earnings, AGL or GDR?

genedrive has lower revenue, but higher earnings than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A genedrive £929K 22.04 -£21.22M -£0.79 N/A

Is AGL or GDR more profitable?

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -732.40%. ANGLE's return on equity of -89.82% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets ANGLE -732.40% -89.82% -29.89% genedrive -500.75% -1,044.57% -74.09%

Which has better earnings and valuation, GENI or GDR?

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GENinCode £2.91M 2.49 -£6.10M -£2.35 N/A genedrive £929K 22.04 -£21.22M -£0.79 N/A

Is GENI or GDR more profitable?

GENinCode has a net margin of -185.47% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -409.40% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets GENinCode -185.47% -409.40% -63.99% genedrive -500.75% -1,044.57% -74.09%

genedrive (GDR) Competitors

GBX 1.27 -0.03 (-1.92%)

As of 06/24/2026 10:37 AM Eastern

Compare

GDR vs. ABDX, YGEN, VRCI, AGL, and GENI

Should you buy genedrive stock or one of its competitors? MarketBeat compares genedrive with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with genedrive include Abingdon Health (ABDX), Yourgene Health (YGEN), Verici Dx (VRCI), ANGLE (AGL), and GENinCode (GENI). These companies are all part of the "diagnostics & research" industry.

How does genedrive compare to Abingdon Health?

Abingdon Health (LON:ABDX) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abingdon Health	£9.57M	2.89	-£796.37K	-£0.81	N/A
genedrive	£929K	22.04	-£21.22M	-£0.79	N/A

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abingdon Health	-33.88%	-55.91%	-17.93%
genedrive	-500.75%	-1,044.57%	-74.09%

3.7% of Abingdon Health shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 8.0% of Abingdon Health shares are held by insiders. Comparatively, 29.0% of genedrive shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Abingdon Health has a beta of 0.18, suggesting that its stock price is 82% less volatile than the broader market. Comparatively, genedrive has a beta of 1.024, suggesting that its stock price is 2% more volatile than the broader market.

In the previous week, Abingdon Health's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company	Overall Sentiment
Abingdon Health	Neutral
genedrive	Neutral

Summary

Abingdon Health beats genedrive on 6 of the 11 factors compared between the two stocks.

How does genedrive compare to Yourgene Health?

genedrive (LON:GDR) and Yourgene Health (LON:YGEN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

genedrive has a beta of 1.024, meaning that its share price is 2% more volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	22.04	-£21.22M	-£0.79	N/A
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Yourgene Health	-27.55%	-27.06%	-6.71%

In the previous week, genedrive's average media sentiment score of 0.00 equaled Yourgene Health'saverage media sentiment score.

Company	Overall Sentiment
genedrive	Neutral
Yourgene Health	Neutral

0.1% of genedrive shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 29.0% of genedrive shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Yourgene Health beats genedrive on 8 of the 10 factors compared between the two stocks.

How does genedrive compare to Verici Dx?

genedrive (LON:GDR) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

genedrive has a beta of 1.024, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Verici Dx has a beta of 1.258, suggesting that its share price is 26% more volatile than the broader market.

Verici Dx has a net margin of -468.31% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -178.37% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Verici Dx	-468.31%	-178.37%	-26.14%

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	22.04	-£21.22M	-£0.79	N/A
Verici Dx	£1.91M	3.16	-£6.56M	-£2.90	N/A

0.1% of genedrive shares are owned by institutional investors. Comparatively, 15.7% of Verici Dx shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 1.2% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Verici Dx had 1 more articles in the media than genedrive. MarketBeat recorded 1 mentions for Verici Dx and 0 mentions for genedrive. genedrive's average media sentiment score of 0.00 beat Verici Dx's score of -1.59 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
Verici Dx	Very Negative

Summary

Verici Dx beats genedrive on 9 of the 13 factors compared between the two stocks.

How does genedrive compare to ANGLE?

ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -732.40%. ANGLE's return on equity of -89.82% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-732.40%	-89.82%	-29.89%
genedrive	-500.75%	-1,044.57%	-74.09%

genedrive has lower revenue, but higher earnings than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A
genedrive	£929K	22.04	-£21.22M	-£0.79	N/A

In the previous week, ANGLE had 1 more articles in the media than genedrive. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for genedrive. genedrive's average media sentiment score of 0.00 beat ANGLE's score of -0.28 indicating that genedrive is being referred to more favorably in the news media.

Company	Overall Sentiment
ANGLE	Neutral
genedrive	Neutral

ANGLE has a beta of 0.22, suggesting that its share price is 78% less volatile than the broader market. Comparatively, genedrive has a beta of 1.024, suggesting that its share price is 2% more volatile than the broader market.

17.5% of ANGLE shares are owned by institutional investors. Comparatively, 0.1% of genedrive shares are owned by institutional investors. 2.7% of ANGLE shares are owned by company insiders. Comparatively, 29.0% of genedrive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

genedrive beats ANGLE on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to GENinCode?

GENinCode (LON:GENI) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

In the previous week, GENinCode's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company	Overall Sentiment
GENinCode	Neutral
genedrive	Neutral

GENinCode has a beta of 0.588, indicating that its share price is 41% less volatile than the broader market. Comparatively, genedrive has a beta of 1.024, indicating that its share price is 2% more volatile than the broader market.

GENinCode has a net margin of -185.47% compared to genedrive's net margin of -500.75%. GENinCode's return on equity of -409.40% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
genedrive	-500.75%	-1,044.57%	-74.09%

GENinCode has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£2.91M	2.49	-£6.10M	-£2.35	N/A
genedrive	£929K	22.04	-£21.22M	-£0.79	N/A

4.5% of GENinCode shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 8.7% of GENinCode shares are held by company insiders. Comparatively, 29.0% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

GENinCode beats genedrive on 7 of the 11 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GDR vs. The Competition

Export

Metric	genedrive	Diagnostics & Research Industry	Medical Sector	LON Exchange
Market Cap	£20.47M	£594.72M	£6.74B	£2.77B
Dividend Yield	1.57%	3.34%	2.68%	6.16%
P/E Ratio	-1.61	78.33	25.37	366.62
Price / Sales	22.04	625.79	530.17	86,103.15
Price / Cash	2.00	11.42	45.29	27.87
Price / Book	0.45	3.37	10.76	7.85
Net Income	-£21.22M	£334.07B	£3.56B	£5.89B
7 Day Performance	-3.41%	0.71%	0.99%	-0.97%
1 Month Performance	11.35%	-3.64%	0.79%	-0.78%
1 Year Performance	-8.93%	3.84%	30.25%	70.21%

genedrive Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDR genedrive	N/A	GBX 1.28 -1.9%	N/A	-13.5%	£20.47M	£929K	N/A	43	Gap Down
ABDX Abingdon Health	N/A	GBX 12.06 -4.3%	N/A	+69.0%	£31.64M	£9.57M	N/A	84	Gap Down
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
VRCI Verici Dx	N/A	GBX 0.37 -1.3%	N/A	-60.0%	£8.30M	£1.91M	N/A	19	Negative News High Trading Volume
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-68.5%	£7.58M	£2.62M	N/A	650	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GDR) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, VRCI, AGL, and GENI

How does genedrive compare to Abingdon Health?

Summary

How does genedrive compare to Yourgene Health?

Summary

How does genedrive compare to Verici Dx?

Summary

How does genedrive compare to ANGLE?

Summary

How does genedrive compare to GENinCode?

Summary

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, VRCI, AGL, and GENI

How does genedrive compare to Abingdon Health?

Which has stronger valuation and earnings, ABDX or GDR?

Is ABDX or GDR more profitable?

Do institutionals & insiders hold more shares of ABDX or GDR?

Which has more volatility & risk, ABDX or GDR?

Does the media prefer ABDX or GDR?

Summary

How does genedrive compare to Yourgene Health?

Which has more risk & volatility, GDR or YGEN?

Which has stronger earnings and valuation, GDR or YGEN?

Is GDR or YGEN more profitable?

Does the media favor GDR or YGEN?

Do insiders and institutionals hold more shares of GDR or YGEN?

Summary

How does genedrive compare to Verici Dx?

Which has more volatility and risk, GDR or VRCI?

Is GDR or VRCI more profitable?

Which has better earnings and valuation, GDR or VRCI?

Do insiders & institutionals believe in GDR or VRCI?

Does the media favor GDR or VRCI?

Summary

How does genedrive compare to ANGLE?

Is AGL or GDR more profitable?

Which has stronger valuation & earnings, AGL or GDR?

Does the media refer more to AGL or GDR?

Which has more volatility and risk, AGL or GDR?

Do institutionals and insiders have more ownership in AGL or GDR?

Summary

How does genedrive compare to GENinCode?

Does the media refer more to GENI or GDR?

Which has more risk and volatility, GENI or GDR?

Is GENI or GDR more profitable?

Which has better earnings and valuation, GENI or GDR?

Do insiders and institutionals have more ownership in GENI or GDR?

Summary

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools